Results 31 to 40 of about 36,206 (260)

Neurological adverse events associated with PD-1/PD-L1 immune checkpoint inhibitors

open access: yesFrontiers in Neuroscience, 2023
Immunotherapy is a promising method for cancer treatment. Among them, immune checkpoint inhibitors targeting PD-1/PD-L1 are increasingly used for certain cancers.
Yanting Zhou, Hongyan Li
doaj   +1 more source

Behavioral Tests in Neurotoxin-Induced Animal Models of Parkinson’s Disease

open access: yesAntioxidants, 2020
Currently, neurodegenerative diseases are a major cause of disability around the world. Parkinson’s disease (PD) is the second-leading cause of neurodegenerative disorder after Alzheimer’s disease.
Maruthi Prasad E, Shih-Ya Hung
semanticscholar   +1 more source

Cerebral Complications of Snakebite Envenoming: Case Studies

open access: yesToxins, 2022
There are an estimated 5.4 million snakebite cases every year. People with snakebite envenoming suffer from severe complications, or even death. Although some review articles cover several topics of snakebite envenoming, a review of the cases regarding ...
Yu-Kai Huang   +5 more
doaj   +1 more source

The mechanisms of action and use of botulinum neurotoxin type A in aesthetics: Key Clinical Postulates II

open access: yesJournal of Cosmetic Dermatology, 2020
The literature on botulinum neurotoxin type A (BoNT‐A) is extensive, often contradictory, and confounded by a competitive market of products and research attempting to distinguish brand individuality.
M. Nestor   +2 more
semanticscholar   +1 more source

Current Perspectives on Reducing the β-ODAP Content and Improving Potential Agronomic Traits in Grass Pea (Lathyrus sativus L.)

open access: yesFrontiers in Plant Science, 2021
Grass pea is well-established as one of the most resilient and versatile crops that can thrive under extreme climatic circumstances such as cold, heat, drought, salt-affected soils, submergence, and excessive rainfall along with resistance to several ...
Arpita Das   +4 more
doaj   +1 more source

Development of Antibody Detection ELISA Based on Immunoreactive Toxins and Toxin-Derived Peptides to Evaluate the Neutralization Potency of Equine Plasma against Naja atra in Taiwan

open access: yesToxins, 2021
Naja atra, also known as Taiwanese cobra, is one of the most prevalent venomous snakes in Taiwan. Clinically, freeze-dried neurotoxic antivenom (FNAV) produced from horses by Taiwan Centers for Disease Control (CDC) has been the only approved treatment ...
Chien-Chun Liu   +6 more
doaj   +1 more source

Botulinum Neurotoxin for the Treatment of Neuropathic Pain

open access: yesFrontiers in Neurology, 2020
Botulinum neurotoxin is widely used for the treatment of central and peripherical neurological conditions. Initially used to treat strabismus, over the years its use has been expanded also to spasticity and other neurological disorders.
G. Egeo, L. Fofi, P. Barbanti
semanticscholar   +1 more source

Breaking down the cellular responses to type I interferon neurotoxicity in the brain

open access: yesFrontiers in Immunology, 2023
Since their original discovery, type I interferons (IFN-Is) have been closely associated with antiviral immune responses. However, their biological functions go far beyond this role, with balanced IFN-I activity being critical to maintain cellular and ...
Barney Viengkhou, Markus J. Hofer
doaj   +1 more source

Incobotulinum Toxin Type A for Treatment of Ultraviolet-B-Induced Hyperpigmentation: A Prospective, Randomized, Controlled Trial

open access: yesToxins, 2022
Incobotulinum toxin A (IncoBoNT-A) is effective in preventing ultraviolet B (UVB)-induced hyperpigmentation. This prospective, randomized, controlled study aimed to evaluate the effect of IncoBoNT-A on the treatment of UVB-induced hyperpigmentation in 15
Vasanop Vachiramon   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy